Svelta Labs
Svelta Labs science for weight, wellness and skin
Svelta Labs Journal

Svelta Labs Education & Research Journal

Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.

Lived Experience with Tirzepatide and Peptide Use in a 1.5-Year Journey
Wellbeing 09 Sep 2026

Lived Experience with Tirzepatide and Peptide Use in a 1.5-Year Journey

A Reddit community member shares a 1.5-year personal journey involving tirzepatide use alongside peptides for pain management and mobility, highlighting lived experience and motivation factors.

 Lived Experience of Adjusting Mounjaro Dose: A Community Perspective
Wellbeing 09 Sep 2026

Lived Experience of Adjusting Mounjaro Dose: A Community Perspective

A personal account from a Mumsnet user describes their experience with an initial 2.5mg dose of Mounjaro, side effects, and considerations around increasing to 5mg. This article explores lived experience alongside current knowledge about such dose adjustments.

 Lived Experience of Starting Weight Loss Injections: A Community Perspective
Wellbeing 09 Sep 2026

Lived Experience of Starting Weight Loss Injections: A Community Perspective

Community members share their non-scale victories and reflections on body changes as they start weight loss injections, highlighting the lived experience behind the journey.

 Endurance Training Insights from the GLP-1 Community
Wellbeing 09 Sep 2026

Endurance Training Insights from the GLP-1 Community

Community members share personal experiences and practical tips for long-distance running and cycling while on GLP-1 medications, highlighting adjustments in nutrition and energy management.

 Managing Constipation During Weight Loss Injections: A Lived Experience
Wellbeing 09 Sep 2026

Managing Constipation During Weight Loss Injections: A Lived Experience

Constipation is a common concern reported by some individuals undergoing weight loss injections. This article explores lived experiences, potential causes, and practical management strategies.
Starting Mounjaro: Portion Control and Everyday Support
Wellbeing

Starting Mounjaro: Portion Control and Everyday Support

Starting Mounjaro? Explore portion control, appetite, daily routines and community support, while keeping personal experiences separate from medical advice.

 Weight-Loss Injection Eligibility Below BMI 27: What Off-Label Means
Wellbeing

Weight-Loss Injection Eligibility Below BMI 27: What Off-Label Means

Starting treatment below BMI 27 is different from reaching that BMI during weight maintenance. Learn how initial BMI, indication and NHS criteria differ.

 Retatrutide Approval Status: Clinical Trials, Not a Licensed Rollout
Research-Use Products

Retatrutide Approval Status: Clinical Trials, Not a Licensed Rollout

Retatrutide remains investigational in the manufacturer’s current information. Claims of a limited public rollout should not be confused with clinical-trial access.

 First Mounjaro Injection Nerves: Preparation and Support
Wellbeing

First Mounjaro Injection Nerves: Preparation and Support

First-injection nerves are understandable. Focus on knowing whom to ask, using the supplied instructions and getting support if anxiety makes treatment difficult.

 Starting Mounjaro: Planning Support Around Everyday Life
Wellbeing

Starting Mounjaro: Planning Support Around Everyday Life

Starting Mounjaro involves more than a prescription. Explore the support, follow-up and practical questions that help people plan around everyday life.

 Mounjaro Expiry Dates and Storage: Planning Your Supply
Wellbeing

Mounjaro Expiry Dates and Storage: Planning Your Supply

Printed expiry and time after first use are different limits. This guide explains how to check a Mounjaro supply without relying on old forum batch dates.

 GLP-1 Medicines and Eating Behaviour: Why Responses May Differ
Slimming Pen News

GLP-1 Medicines and Eating Behaviour: Why Responses May Differ

A 92-person observational study linked external eating scores with weight change. It does not prove that emotional eaters cannot benefit from GLP-1 medicines.

 Weight Regain After Stopping GLP-1 Medicines: Evidence and Support
Wellbeing

Weight Regain After Stopping GLP-1 Medicines: Evidence and Support

Experiences after stopping GLP-1 medicines vary. Clinical withdrawal studies show why weight maintenance needs continuing support rather than blame.

 Mounjaro KwikPen “Golden Dose”: New Pens and Leftover Medicine
Wellbeing

Mounjaro KwikPen “Golden Dose”: New Pens and Leftover Medicine

A modified Mounjaro KwikPen can look different, but both versions deliver four fixed doses. Leftover solution is not a validated extra dose.

 BRP Peptide and Appetite: What Stanford’s Animal Research Found
Weight Science

BRP Peptide and Appetite: What Stanford’s Animal Research Found

Stanford’s BRP discovery links computational peptide screening with appetite research in animals. It does not yet establish human benefit or comparative safety.

 Intermittent Fasting and the Gut Microbiome: A Brain–Gut Study
Weight Science

Intermittent Fasting and the Gut Microbiome: A Brain–Gut Study

A small study tracked gut bacteria and brain activity during intermittent energy restriction. Its associations raise questions rather than establish a fasting prescription.

 Wegovy Tablets UK Approval: Oral Semaglutide and Access
Research & Regulation

Wegovy Tablets UK Approval: Oral Semaglutide and Access

Wegovy tablets received UK authorisation in June 2026. Regulatory approval, actual supply and NHS funding are separate steps.